Chemours Company (CC) has disclosed a new risk, in the Accounting & Financial Operations category.
The Chemours Company faces substantial financial strain as it allocates considerable resources to addressing the Audit Committee Internal Review and remediating internal control deficiencies. This situation necessitates hefty expenditures for professional services and system overhauls, further compounded by indemnification obligations to certain executives and directors. Although remedial actions have been taken, their effectiveness remains uncertain, with potential for additional costly measures. Such financial commitments could materially impact the company’s operational performance, financial stability, and ability to pursue strategic business objectives.
The average CC stock price target is $30.00, implying 14.24% upside potential.
To learn more about Chemours Company’s risk factors, click here.
